 Connection
Qiang Fu to Antineoplastic Agents
This is a "connection" page, showing publications Qiang Fu has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.072 |
|
|
|
-
Fu Q, Wu X, Lu Z, Chang Y, Jin Q, Jin T, Zhang M. TMEM205 induces TAM/M2 polarization to promote cisplatin resistance in gastric cancer. Gastric Cancer. 2024 Sep; 27(5):998-1015.
Score: 0.493
-
Fu Q, Jin X, Zhang Z, Lv H. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS. Int J Pharm. 2020 Jun 30; 584:119432.
Score: 0.373
-
Xu J, Zhong Y, Qin M, Zhang Y, Ma Y, Hu B, Fu Q, Sun Y, Cheng M, Liu Y, Li J. Discovery and Administration Optimization of Novel Selective CDK9 Inhibitor, 1-7a-B1, for Improved Pharmacokinetics and Antitumor Efficacy In Vivo. J Med Chem. 2025 Jun 12; 68(11):11586-11605.
Score: 0.132
-
Li D, Fu Q, Li M, Li J, Yin C, Zhao J, Li F. Primary tumor site and anti-EGFR monoclonal antibody benefit in metastatic colorectal cancer: a meta-analysis. Future Oncol. 2017 May; 13(12):1115-1127.
Score: 0.074
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|